Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/264118
COMPARTIR / EXPORTAR:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Radioligand Binding Detection of Receptors in Brain Membranes

AutorPilar-Cuéllar, Fuencisla CSIC ORCID; Garro-Martínez, Emilio CSIC ORCID; Castro, Elena CSIC ORCID; Díaz, Álvaro CSIC ORCID
Palabras claveRadioligand
Membrane homogenates
Saturation binding assays
Competition binding assays
[35S]GTPγS receptor binding
Affinity
Efficacy
Functionality
Fecha de publicación2021
EditorHumana Press
Springer Nature
CitaciónReceptor and Ion Channel Detection in the Brain. Neuromethods: 67- 85 (2021)
ResumenTransmitters, hormones, and most of the therapeutic drugs exert their biological functions by generating signals in target cells through interaction with a receptor molecule in the cellular membrane, cytosol, or even at the nucleus of the cell. Because receptors play such a crucial role in cell function, especially within the central nervous system (CNS), we need lab techniques to measure their expression and functionality. There are techniques to determine regulatory changes in receptor number (receptor density), subcellular distribution, anatomical distribution, the physiological function of the receptors as well as the ligand affinity. Here, we describe a classic method in which cells or tissue membranes are exposed to radiolabeled molecules (radioligands) that bind selectively to the receptors in the sample (receptor binding assay). Similarly, the functional consequence of the receptor occupancy or level of G protein activation can be measured by [35S]GTPγS binding assay, also known as functional binding. This assay measures the binding of the nonhydrolyzable analog [35S]GTPγS ([35S]guanosine-5′-O-(3-thio) triphosphate) to Gα subunits. The above radiometric assays are useful to determine the affinity and receptor density of a drug, and to differentiate among agonist, antagonist, and inverse agonist activities, the traditional pharmacological parameters of potency and efficacy, as well as receptor constitutive activity. Moreover, radioligand binding assays provide a powerful tool for screening drug candidates for many receptors in drug discovery research.
Versión del editorhttps://doi.org/10.1007/978-1-0716-1522-5_6
URIhttp://hdl.handle.net/10261/264118
DOI10.1007/978-1-0716-1522-5_6
ISBN978-1-0716-1521-8
978-1-0716-1522-5
Aparece en las colecciones: (IBBTEC) Libros y partes de libros




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
accesoRestringido.pdf15,38 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

Page view(s)

46
checked on 29-mar-2024

Download(s)

10
checked on 29-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.